Anna Sieweke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna Sieweke has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arne Streitbürger
Department of General Orthopaedics and Tumor Orthopaedics, University Hospital, Albert-Schweitzer-Campus 1, 48149, Münster, Germany
1 shared publication - Georg Gosheger
Department of Orthopedics and Tumororthopedics, University Hospital Munster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany
1 shared publication - Helmut Ahrens
Department of Orthopedics and Tumor Orthopedics, Muenster University Hospital, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany
1 shared publication - Jendrik Hardes
Universitätsklinikum Münster
1 shared publication - Ralf Dieckmann
Department of General Orthopaedics and Tumor Orthopaedics, University Hospital, Albert-Schweitzer-Campus 1, 48149, Münster, Germany
1 shared publication - Steffen Hoell
Department of Orthopaedics, Paracelsus Hospital, Am Natruper Holz 69, 49076, Osnabrück, Germany.
1 shared publication
Latest Publications
- Open Access
- 26 August 2016
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 11 (1) , 1-6
Eradication rates, risk factors, and implant selection in two-stage revision knee arthroplasty: a mid-term follow-up study
Two-stage revision (TSR) knee arthroplasty is an established treatment, but failure to control infection still occurs in 4–50 % of cases. The aim of this study was to assess the infection eradication rate, risk factors for failure, and the clinical outcome after two-stage revision knee arthroplasty. This retrospective study included 59 patients who had undergone at least one two-stage revision procedure due to periprosthetic joint infection (PJI). Demographic data, comorbidities, types of implant, and complications were analyzed. Univariate and multivariate logistic regression analysis were used to identify risk factors for failure. The infections were controlled in 55 patients (93.2 %). The follow-up period was 4.1 (±2.7) years. Infection control was achieved after the first TSR in 42 patients (71.2 %) and after the second TSR in 13 (76.5 %). The percentage of arthrodesis procedures in patients with infection control increased from 16.75 % after one TSR to 69.2 % after two TSRs. Multivariate logistic regression analysis identified body mass index (BMI) (odds ratio 1.22; 95 % confidence intervals, 1.07 to 1.40; p = 0.004) and smoking (OR 21.52; 95 % CI, 2.60 to 178.19; p = 0.004) as risk factors for failure. Two-stage revision protocols can achieve acceptable results even after a second procedure. It is still unclear whether the choice of implant influences failure rates. Risk factors for failure after two-stage revision were identified. Studies with larger sample sizes are needed in order to support these findings and identify further risk factors. To reduce failure rates, programs should be established to treat or minimize risk factors in patients with PJI.
- 26 August 2016
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 11 (1) , 1-6
Open AccessEradication rates, risk factors, and implant selection in two-stage revision knee arthroplasty: a mid-term follow-up study
Two-stage revision (TSR) knee arthroplasty is an established treatment, but failure to control infection still occurs in 4–50 % of cases. The aim of this study was to assess the infection eradication rate, risk factors for failure, and the clinical outcome after two-stage revision knee arthroplasty. This retrospective study included 59 patients who had undergone at least one two-stage revision procedure due to periprosthetic joint infection (PJI). Demographic data, comorbidities, types of implant, and complications were analyzed. Univariate and multivariate logistic regression analysis were used to identify risk factors for failure. The infections were controlled in 55 patients (93.2 %). The follow-up period was 4.1 (±2.7) years. Infection control was achieved after the first TSR in 42 patients (71.2 %) and after the second TSR in 13 (76.5 %). The percentage of arthrodesis procedures in patients with infection control increased from 16.75 % after one TSR to 69.2 % after two TSRs. Multivariate logistic regression analysis identified body mass index (BMI) (odds ratio 1.22; 95 % confidence intervals, 1.07 to 1.40; p = 0.004) and smoking (OR 21.52; 95 % CI, 2.60 to 178.19; p = 0.004) as risk factors for failure. Two-stage revision protocols can achieve acceptable results even after a second procedure. It is still unclear whether the choice of implant influences failure rates. Risk factors for failure after two-stage revision were identified. Studies with larger sample sizes are needed in order to support these findings and identify further risk factors. To reduce failure rates, programs should be established to treat or minimize risk factors in patients with PJI.